Call to Schedule Free Consultation at Over 45 Centers Worldwide!
MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, stands at the forefront of regenerative medicine and healthcare innovation, blending clinical expertise with entrepreneurial vision. As the founder and CEO of R3 Stem Cell and US Lead Network, Dr. Greene has dedicated his career to advancing patient care and empowering medical practices through advanced therapies and digital marketing excellence.
A residency and fellowship-trained orthopedic surgeon, Dr. Greene began his journey in medicine with a deep commitment to helping others. After years in clinical practice, he recognized the transformative potential of regenerative therapies and the urgent need for better patient access and education. This insight led him to establish R3 Stem Cell, now a global leader in non-surgical treatment options using stem cell and PRP therapy. Under his leadership, R3 Stem Cell has performed over 26,000 procedures across more than 45 international clinics, offering hope and healing to patients worldwide.
Dr. Greene’s entrepreneurial spirit didn’t stop at clinical innovation. He also founded US Lead Network, a healthcare internet marketing company that leverages artificial intelligence to help medical and dental practices grow their patient base efficiently and ethically. His two books on healthcare internet marketing have become essential reading for providers seeking to navigate the complexities of digital patient acquisition. Recognized as a Top 20 Expert Author by Ezines.com – ranking #15 out of over 470,000 authors and #1 in Pain Management – Dr. Greene’s thought leadership has shaped the way healthcare professionals connect with patients online.
A defining moment in Dr. Greene’s career was his decision to leave clinical practice and focus entirely on innovation and education. “I’ve never been a fan of just settling for the status quo. Innovation is a cornerstone of what makes America great,” he reflects. This philosophy has driven R3 Stem Cell’s mission to provide affordable, high-quality regenerative care and to demystify stem cell therapies through comprehensive training courses and educational content for both providers and patients.
Dr. Greene’s work has garnered international recognition, including a feature on the cover of Corporate Vision magazine, where his commitment to affordable, accessible regenerative therapies was spotlighted. His impact extends beyond business metrics – he is known for his compassionate approach, always prioritizing patient education and ethical practice.
Outside of his professional life, Dr. Greene is inspired by the words of Maya Angelou: “My mission in life is not merely to survive, but to thrive; and to do so with some passion, some compassion, some humor, and some style”. He brings this ethos to his daily work, fostering a culture of innovation, empathy, and continuous learning.
When he’s not leading global healthcare initiatives, Dr. Greene enjoys sharing insights on social media, connecting with colleagues, and pursuing personal interests that keep him grounded and inspired.
Dr. David Greene’s journey is a testament to the power of combining clinical skill, business acumen, and a heartfelt commitment to making a difference – one patient, one practice, and one innovation at a time.
All Posts
There have been a lot of conflicting stories about the use of stem cells in regenerative therapy in recent years. The truth has become shrouded in sensationalism and misinformation. This article addresses some of the major questions about stem cell therapy in order to clear
Hi, it’s Dr. David Greene, Founder and CEO of R3 Stem Cell, the nation’s leader in Regenerative Medicine Therapies. Today’s topic is the five main differences between bone marrow and umbilical stem cell therapy. Now, umbilical, I’m going to refer to more as perinatal, and
Would you like your practice’s regenerative program to be part of an approved IRB protocol? R3 Stem Cell is now offering that option with its recent IRB approved study titled “Safety and Clinical Outcomes Study: Amniotic and Umbilical Cord Tissue Administration for Orthopedic, Neurologic, Urologic,
Arthritis is a condition in which the joints get inflamed. There are many types of arthritis based on the underlying cause. The joints of the hands are most commonly affected by rheumatoid arthritis (RA). It is characterized by inflammation and irritation the sign of synovial
Stem cells are pluripotent cells derived from either adult, placenta or embryonic sources that are capable of differentiating into a number of cell lineages. Based on this property, they have the potential of (or are) being used to regenerate or repair damaged tissue and help
Trigeminal neuralgia is an extremely painful condition characterized by irritation of the trigeminal nerve resulting in sharp shooting pain along its distribution. The pain can be so severe that it is disabling. The diagnosis is difficult as it can be confused with other disorders. There
Hi, it’s Dr. David Greene, Founder, and CEO of R3 Stem Cell, the nation’s leader in Regenerative Medicine Therapies. Today I want to talk about international stem cell therapy and why nobody needs to that anymore. There are plenty of international stem cell clinics from
Hi, it’s Dr. David Greene, Founder, and CEO of R3 Stem Cell, the nation’s leader in Regenerative Medicine Therapies. I’ve gotten a lot of emails over the last year with people asking me, should I leave the country to have stem cell therapy? The answer
Hi, it’s Dr. David Greene, Founder, and CEO of R3 Stem Cell, the nation’s leader in Regenerative Medicine Therapies. Today the topic is, Is Financing Available for a Regenerative Cell Therapy? And the answer is, absolutely! We have no less than three options at our
Hi, It’s Dr. David Greene, Founder, and CEO of R3 Stem Cell, the nation’s leader in Regenerative Medicine Therapies. The main question that we get asked all the time is, how much does it cost, and that’s a legitimate question, people need to know that
